BROWSE

Cited 0 times in Scipus Cited Count

Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial

DC Field Value Language
dc.contributor.authorKim, HA-
dc.contributor.authorLee, JW-
dc.contributor.authorNam, SJ-
dc.contributor.authorPark, BW-
dc.contributor.authorIm, SA-
dc.contributor.authorLee, ES-
dc.contributor.authorJung, YS-
dc.contributor.authorYoon, JH-
dc.contributor.authorKang, SS-
dc.contributor.authorLee, SJ-
dc.contributor.authorPark, KH-
dc.contributor.authorJeong, J-
dc.contributor.authorCho, SH-
dc.contributor.authorKim, SY-
dc.contributor.authorKim, LS-
dc.contributor.authorMoon, BI-
dc.contributor.authorLee, MH-
dc.contributor.authorKim, TH-
dc.contributor.authorPark, C-
dc.contributor.authorJung, SH-
dc.contributor.authorGwak, G-
dc.contributor.authorKim, J-
dc.contributor.authorKang, SH-
dc.contributor.authorJin, YW-
dc.contributor.authorKim, HJ-
dc.contributor.authorHan, SH-
dc.contributor.authorHan, W-
dc.contributor.authorHur, MH-
dc.contributor.authorNoh, WC-
dc.contributor.authorKorean Breast Cancer Study Group-
dc.date.accessioned2022-11-11T04:09:30Z-
dc.date.available2022-11-11T04:09:30Z-
dc.date.issued2020-
dc.identifier.issn0732-183X-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/22526-
dc.description.abstractPURPOSE: The addition of ovarian function suppression (OFS) for 5 years to tamoxifen (TAM) for treatment of premenopausal patients with breast cancer after completion of chemotherapy has beneficial effects on disease-free survival (DFS). This study evaluated the efficacy of adding 2 years of OFS to TAM in patients with hormone receptor-positive breast cancer who remain in a premenopausal state or resume ovarian function after chemotherapy. PATIENTS AND METHODS: We enrolled 1,483 premenopausal women (age-
dc.language.isoen-
dc.subject.MESHAdult-
dc.subject.MESHAntineoplastic Agents, Hormonal-
dc.subject.MESHBreast Neoplasms-
dc.subject.MESHDisease-Free Survival-
dc.subject.MESHFemale-
dc.subject.MESHFollicle Stimulating Hormone-
dc.subject.MESHGonadotropin-Releasing Hormone-
dc.subject.MESHHumans-
dc.subject.MESHMiddle Aged-
dc.subject.MESHOvary-
dc.subject.MESHPremenopause-
dc.subject.MESHTamoxifen-
dc.titleAdding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial-
dc.typeArticle-
dc.identifier.pmid31518174-
dc.contributor.affiliatedAuthorJung, YS-
dc.contributor.affiliatedAuthorHan, SH-
dc.type.localJournal Papers-
dc.identifier.doi10.1200/JCO.19.00126-
dc.citation.titleJournal of clinical oncology-
dc.citation.volume38-
dc.citation.number5-
dc.citation.date2020-
dc.citation.startPage434-
dc.citation.endPage443-
dc.identifier.bibliographicCitationJournal of clinical oncology, 38(5). : 434-443, 2020-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.identifier.eissn1527-7755-
dc.relation.journalidJ00732183X-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Surgery
Journal Papers > School of Medicine / Graduate School of Medicine > Medical Science
Files in This Item:
There are no files associated with this item.
Show simple item record

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

  • License
    sherpa_romeo
    sherpa_juliet

OAK

Ajou University Medical Information & Media Center 164 Worldcup-ro Yeongtong-gu Suwon 16499 Korea / TEL : 031-219-5312
Copyright (c) Ajou University Medical Information & Media Center All Rights Reserved.
AJOU Open Repository는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Guide 아주대학교 의학문헌정보센터